应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
STAA STAAR Surgical Company
休市中 05-01 16:00:00 EDT
27.19
+0.83
+3.15%
盘后
26.95
-0.24
-0.88%
17:13 EDT
最高
27.23
最低
26.08
成交量
97.47万
今开
26.41
昨收
26.36
日振幅
4.36%
总市值
13.52亿
流通市值
8.15亿
总股本
4,974万
成交额
2,621万
换手率
3.25%
流通股本
2,998万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读 | 业绩指引超预期叠加中国市场恢复,STAAR Surgical盘中大涨5.24%
异动解读 · 04-10
异动解读 | 业绩指引超预期叠加中国市场恢复,STAAR Surgical盘中大涨5.24%
异动解读 | 获机构上调评级及一季度销售额指引超预期,STAAR Surgical盘中大涨25.14%
异动解读 · 04-09
异动解读 | 获机构上调评级及一季度销售额指引超预期,STAAR Surgical盘中大涨25.14%
STAAR Surgical暴涨25%,Q1业绩大增、超预期并获上调评级
老虎资讯综合 · 04-09
STAAR Surgical暴涨25%,Q1业绩大增、超预期并获上调评级
异动解读 | 获机构上调评级及目标价,STAAR Surgical盘前大涨21.84%
异动解读 · 04-09
异动解读 | 获机构上调评级及目标价,STAAR Surgical盘前大涨21.84%
异动解读 | 获机构上调评级及目标价,STAAR Surgical夜盘大涨24.47%
异动解读 · 04-09
异动解读 | 获机构上调评级及目标价,STAAR Surgical夜盘大涨24.47%
Staar Surgical Company2025财年实现净利润-80.45百万美元,同比减少298.07%
市场透视 · 03-09
Staar Surgical Company2025财年实现净利润-80.45百万美元,同比减少298.07%
FDA扩大Evo ICL在美国适用年龄范围,长期安全数据强化市场从激光视力矫正转向趋势
美股速递 · 02-18
FDA扩大Evo ICL在美国适用年龄范围,长期安全数据强化市场从激光视力矫正转向趋势
华尔街顶级分析师最新评级:奥多比遭下调,帕兰提尔获上调
环球市场播报 · 02-03
华尔街顶级分析师最新评级:奥多比遭下调,帕兰提尔获上调
STAAR Surgical Company:双方均无需支付终止费,公司将保持独立上市地位
美股速递 · 01-06
STAAR Surgical Company:双方均无需支付终止费,公司将保持独立上市地位
Alcon行使权利要求STAAR Surgical推迟股东特别会议,现将于1月6日举行
美股速递 · 2025-12-20
Alcon行使权利要求STAAR Surgical推迟股东特别会议,现将于1月6日举行
Broadwood Partners - 我们鼓励股东仔细审阅我们的演示文稿并在即将召开的股东特别会议上投票“反对”修订交易
美股速递 · 2025-12-11
Broadwood Partners - 我们鼓励股东仔细审阅我们的演示文稿并在即将召开的股东特别会议上投票“反对”修订交易
Broadwood Partners: 再次敦促STAAR股东投票“反对”提议交易
美股速递 · 2025-12-10
Broadwood Partners: 再次敦促STAAR股东投票“反对”提议交易
美股异动 | STAAR Surgical(STAA.US)盘前大涨超15% Alcon将收购报价提高至16亿美元
智通财经 · 2025-12-09
美股异动 | STAAR Surgical(STAA.US)盘前大涨超15% Alcon将收购报价提高至16亿美元
Alcon AG - Alcon敦促STAAR股东在2025年12月19日会议之前投票支持交易
美股速递 · 2025-12-09
Alcon AG - Alcon敦促STAAR股东在2025年12月19日会议之前投票支持交易
Alcon AG - 新条款包括收购价格上涨及高管薪酬减少
美股速递 · 2025-12-09
Alcon AG - 新条款包括收购价格上涨及高管薪酬减少
Broadwood Partners 重申反对 STAAR Surgical 出售给 Alcon
美股速递 · 2025-12-09
Broadwood Partners 重申反对 STAAR Surgical 出售给 Alcon
Broadwood Partners:代理咨询公司Egan-Jones重申STAA Surgical股东投票反对出售给Alcon
美股速递 · 2025-12-08
Broadwood Partners:代理咨询公司Egan-Jones重申STAA Surgical股东投票反对出售给Alcon
Broadwood Partners:正努力召集STAAR Surgical股东特别会议,罢免三名董事
美股速递 · 2025-12-03
Broadwood Partners:正努力召集STAAR Surgical股东特别会议,罢免三名董事
异动解读 | STAAR Surgical盘中大涨5.05%,第三季度业绩强劲获投资者青睐
异动解读 · 2025-11-07
异动解读 | STAAR Surgical盘中大涨5.05%,第三季度业绩强劲获投资者青睐
异动解读 | STAAR Surgical盘中大涨5.05%,强劲业绩及股东建议提振股价
异动解读 · 2025-11-07
异动解读 | STAAR Surgical盘中大涨5.05%,强劲业绩及股东建议提振股价
加载更多
公司概况
公司名称:
STAAR Surgical Company
所属市场:
NASDAQ
上市日期:
--
主营业务:
Staar Surgical Company最初于1982年在加利福尼亚州注册成立,并于1986年在特拉华州重新注册。该公司设计、开发、制造和销售用于眼睛的植入式镜片,主要是用于矫正性屈光手术的可植入胶原镜片。公司已逐步淘汰其白内障人工晶状体产品线,以专注于其ICL产品。
发行价格:
--
{"stockData":{"symbol":"STAA","market":"US","secType":"STK","nameCN":"STAAR Surgical Company","latestPrice":27.19,"timestamp":1777665600000,"preClose":26.36,"halted":0,"volume":974736,"hourTrading":{"tag":"盘后","latestPrice":26.95,"preClose":27.19,"latestTime":"17:13 EDT","volume":42379,"amount":1145380.03,"timestamp":1777670035396,"change":-0.24,"changeRate":-0.008827,"amplitude":0.008827},"delay":0,"changeRate":0.03148710166919582,"floatShares":29975939,"shares":49741953,"eps":-1.622982,"marketStatus":"休市中","change":0.83,"latestTime":"05-01 16:00:00 EDT","open":26.41,"high":27.23,"low":26.08,"amount":26211768.087456,"amplitude":0.043627,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.622982,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777881600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":26.36,"preHourTrading":{"tag":"盘前","latestPrice":26.2,"preClose":26.36,"latestTime":"08:27 EDT","volume":1133,"amount":29888.898028,"timestamp":1777638467865,"change":-0.16,"changeRate":-0.00607,"amplitude":0.052731},"postHourTrading":{"tag":"盘后","latestPrice":26.95,"preClose":27.19,"latestTime":"17:13 EDT","volume":42379,"amount":1145380.03,"timestamp":1777670035396,"change":-0.24,"changeRate":-0.008827,"amplitude":0.008827},"volumeRatio":1.4896362564151564,"impliedVol":0.6245,"impliedVolPercentile":0.4024},"requestUrl":"/m/hq/s/STAA","defaultTab":"news","newsList":[{"id":"1183149257","title":"异动解读 | 业绩指引超预期叠加中国市场恢复,STAAR Surgical盘中大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=1183149257","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183149257?lang=zh_cn&edition=full","pubTime":"2026-04-10 22:37","pubTimestamp":1775831831,"startTime":"0","endTime":"0","summary":"STAAR Surgical Company(STAA)今日盘中大涨5.24%,引起了市场的广泛关注。消息面上,该公司于前一日盘后公布的2026年第一季度初步业绩指引大幅超出市场预期,预计净销售额将超过9000万美元,较2025年同期增长逾一倍,远超分析师此前预期。此外,STAAR Surgical在中国市场的库存已恢复正常范围,供货全面恢复,同时新一代产品EVO+ ICL(V5)已在中国正式上市,这些积极因素共同推动了股价的上涨。多家机构也因此上调了对该公司的评级和目标价,进一步增强了市场信心。STAAR Surgical作为全球植入式隐形眼镜市场的领导者,正从之前的低谷中重拾增长动能。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"40c55708269c8fdd426cc05dfae7d745","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["STAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155907159","title":"异动解读 | 获机构上调评级及一季度销售额指引超预期,STAAR Surgical盘中大涨25.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155907159","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155907159?lang=zh_cn&edition=full","pubTime":"2026-04-09 22:26","pubTimestamp":1775744815,"startTime":"0","endTime":"0","summary":"STAAR Surgical Company今日盘中大幅上涨25.14%,引起了市场的广泛关注。消息面上,此次股价大涨主要受到两方面利好消息推动。首先,Canaccord Genuity将STAAR Surgical的股票评级从“持有”上调至“买入”,同时将其目标价从22美元上调至27美元,这反映了机构对公司未来前景的乐观看法。其次,公司公布的2026年第一季度初步净销售额指引表现强劲。预计第一季度净销售额将超过9000万美元,较2025年同期的4260万美元增长超过一倍,并大幅超出分析师平均预期的7300万美元。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"40c55708269c8fdd426cc05dfae7d745","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["STAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182750408","title":"STAAR Surgical暴涨25%,Q1业绩大增、超预期并获上调评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1182750408","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182750408?lang=zh_cn&edition=full","pubTime":"2026-04-09 22:25","pubTimestamp":1775744747,"startTime":"0","endTime":"0","summary":"第一财季初步净销售额超过9000万美元。","market":"us","thumbnail":"https://static.tigerbbs.com/4d75360c9c1cef3b8390d9dc6c7c572d","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/4d75360c9c1cef3b8390d9dc6c7c572d"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"40c55708269c8fdd426cc05dfae7d745","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186621967","title":"异动解读 | 获机构上调评级及目标价,STAAR Surgical盘前大涨21.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186621967","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186621967?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:05","pubTimestamp":1775721927,"startTime":"0","endTime":"0","summary":"STAAR Surgical Company(STAA)今日盘前股价大幅上涨21.84%,引起了市场的广泛关注。消息面上,Canaccord Genuity将STAAR Surgical的股票评级从“持有”上调至“买入”,同时将其目标价从22美元上调至27美元。分析师评级和目标价的上调,通常反映了机构对公司未来业绩和增长潜力的乐观预期,这直接提振了市场信心,推动了股价在盘前时段的强劲上涨。此次评级调整是华尔街证券分析师当日发布的众多研究报告之一,凸显了机构对STAAR Surgical在医疗设备领域前景的看好。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0675eca0289af7f2f4e85108fb371c4f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["STAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176074430","title":"异动解读 | 获机构上调评级及目标价,STAAR Surgical夜盘大涨24.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=1176074430","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176074430?lang=zh_cn&edition=full","pubTime":"2026-04-09 15:54","pubTimestamp":1775721283,"startTime":"0","endTime":"0","summary":"STAAR Surgical Company(STAA)在今日夜盘交易中股价大幅上涨24.47%,引起了市场的广泛关注。消息面上,Canaccord Genuity将STAAR Surgical的股票评级从“持有”上调至“买入”,同时将其目标价从22美元上调至27美元。分析师评级和目标价的上调,通常反映了机构对公司未来业绩和增长潜力的乐观预期,这直接提振了市场信心,推动了股价在夜盘时段强劲上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0675eca0289af7f2f4e85108fb371c4f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["STAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618614296","title":"Staar Surgical Company2025财年实现净利润-80.45百万美元,同比减少298.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618614296","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618614296?lang=zh_cn&edition=full","pubTime":"2026-03-09 00:00","pubTimestamp":1772985618,"startTime":"0","endTime":"0","summary":"3月9日,Staar Surgical Company公布财报,公告显示公司2025财年净利润为-80.45百万美元,同比减少298.07%;其中营业收入为2.39亿美元,同比减少23.89%,每股基本收益为-1.62美元。从资产负债表来看,Staar Surgical Company总负债1.17亿美元,其中短期债务5.87百万美元,资产负债比为3.95,流动比率为0.05。机构评级:截至2026年3月9日,当前有10家机构对Staar Surgical Company目标价做出预测,其中目标均价为20.05美元,其中最低目标价为13.00美元,最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309000028a4587830&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309000028a4587830&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","ICL","BK4548","STAA","BK4093","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150710853","title":"FDA扩大Evo ICL在美国适用年龄范围,长期安全数据强化市场从激光视力矫正转向趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=1150710853","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150710853?lang=zh_cn&edition=full","pubTime":"2026-02-18 05:02","pubTimestamp":1771362136,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局近日批准扩大STAAR Surgical公司生产的Evo ICL的适用年龄范围。这一决定基于长期安全数据的支持,进一步印证了视力矫正市场正逐渐从激光手术向植入式解决方案转移的趋势。随着更多临床证据表明Evo ICL在长期使用中的安全性表现优异,医疗界对可植入式视力矫正技术的认可度持续提升。此次FDA的批准不仅拓宽了该产品的适用人群,更凸显出眼科医疗领域技术路线的重大转变。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","STAA","BK4548","BK4198","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608899870","title":"华尔街顶级分析师最新评级:奥多比遭下调,帕兰提尔获上调","url":"https://stock-news.laohu8.com/highlight/detail?id=2608899870","media":"环球市场播报","labels":["rating"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608899870?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:46","pubTimestamp":1770129960,"startTime":"0","endTime":"0","summary":"华尔街最受关注、对市场影响显著的分析师评级报告现已汇总呈现。以下为 The Fly 整理的、投资者需重点关注的今日最新评级调整信息。该行称,估值因素是此次评级下调的核心原因,目前埃克森美孚的市盈率处于五年高位。该行对阿克蒂斯肿瘤的发展前景持积极态度:公司正致力于拓展放射性药物的治疗靶点领域,其管线项目有望成为首款同类创新药。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-03/doc-inhkqfvc7106899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"rating","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2317271919.USD","LU1720051017.SGD","LU1815333072.USD","LU1235294995.USD","CTRA","IE00BFXG0V08.USD","BK4581","LU1674673428.USD","IE00BQXX3F31.USD","LU0557290698.USD","AFRM","LU0792757196.USD","LU0942090050.USD","LU0708995401.HKD","XOM","LU0082616367.USD","LU0106261372.USD","LU0170899867.USD","LU0289961442.SGD","ELV","MA","LU1046421795.USD","LU0342679015.USD","LU0061474960.USD","LU0348723411.USD","LU0158827948.USD","BK4592","LU1261432733.SGD","SGXZ51526630.SGD","ADBE","BK4585","LU0234572021.USD","LU2023251221.USD","LU2236285917.USD","LU2458330243.SGD","BK4527","IE00BQXX3D17.EUR","IE00B5TLWC47.USD","LU2360032135.SGD","LU2458330169.SGD","LU0345774391.USD","LU0965509283.SGD","IE00B19Z9505.USD","LU0889565833.HKD","LU0719512351.SGD","LU0965509101.SGD","BK4566","JBLU","LU0345774631.USD","BK4023","FIGR","SG9999001424.SGD","BK4528","LU0861579265.USD","LU0109392836.USD","LU2210149790.SGD","LU0957791311.USD","LU0672654240.SGD","TASK","LU0109391861.USD","LU1823568750.SGD","LU0868494617.USD","LU1720051108.HKD","LU2357305700.SGD","LU2125154778.USD","BK4543","LU1633808545.USD","BK4534","LU1267930813.SGD","PLTR","STAA","LU1119994496.HKD","LU2237438978.USD","BK4588","LU0965509010.AUD","AKTS","LU2089283258.USD","SGXZ81514606.USD","LU2089284900.SGD","LU0198837287.USD","LU0057025933.USD","SG9999000418.SGD","BK4567","LU0234570918.USD","SGXZ99366536.SGD","LU1674673691.USD","LU0472753341.HKD","LU1366333091.USD","LU1548497426.USD","LU1712237335.SGD","LU0157215616.USD","LU0314104364.USD","BK4554","IE00BQXX3C00.GBP","LU1267930730.SGD","LU0006306889.USD","LU1623119135.USD","LU1778281490.HKD","QTWO","LU0081259029.USD","BK4533","LU1691799644.USD","LU1803068979.SGD","LU0868494708.USD","IE0009356076.USD","LU0320765059.SGD","LU2125154935.USD","SGMT","DIS","IE00BYQQ9H92.USD","LU0889566641.SGD","LU1084165304.USD","LU2095319765.USD","LU0069063385.USD","LU2210150020.SGD","LU0289739343.SGD","LU0511384066.AUD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1106938458","title":"STAAR Surgical Company:双方均无需支付终止费,公司将保持独立上市地位","url":"https://stock-news.laohu8.com/highlight/detail?id=1106938458","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106938458?lang=zh_cn&edition=full","pubTime":"2026-01-06 21:50","pubTimestamp":1767707406,"startTime":"0","endTime":"0","summary":"STAAR Surgical Company近日明确声明,其与相关方的合作协议中规定,若协议终止,任何一方均无需支付终止费用。该公司强调,其战略定位保持不变,将继续作为独立的公开上市公司运营。这一表态进一步巩固了STAAR在眼科医疗技术领域的自主发展路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","STAA","BK4585","BK4548","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161917990","title":"Alcon行使权利要求STAAR Surgical推迟股东特别会议,现将于1月6日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=1161917990","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161917990?lang=zh_cn&edition=full","pubTime":"2025-12-20 00:43","pubTimestamp":1766162620,"startTime":"0","endTime":"0","summary":"Alcon行使权利要求STAAR Surgical推迟股东特别会议,现将于1月6日举行","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4585","BK4588","BK4198","STAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134057146","title":"Broadwood Partners - 我们鼓励股东仔细审阅我们的演示文稿并在即将召开的股东特别会议上投票“反对”修订交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1134057146","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134057146?lang=zh_cn&edition=full","pubTime":"2025-12-11 20:05","pubTimestamp":1765454759,"startTime":"0","endTime":"0","summary":"Broadwood Partners - 我们鼓励股东仔细审阅我们的演示文稿并在即将召开的股东特别会议上投票“反对”修订交易","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","BK4588","BK4585","BK4548","STAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138909533","title":"Broadwood Partners: 再次敦促STAAR股东投票“反对”提议交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1138909533","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138909533?lang=zh_cn&edition=full","pubTime":"2025-12-10 01:40","pubTimestamp":1765302012,"startTime":"0","endTime":"0","summary":"Broadwood Partners: 再次敦促STAAR股东投票“反对”提议交易","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","STAA","BK4548","BK4585","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590424533","title":"美股异动 | STAAR Surgical(STAA.US)盘前大涨超15% Alcon将收购报价提高至16亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590424533","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590424533?lang=zh_cn&edition=full","pubTime":"2025-12-09 22:23","pubTimestamp":1765290200,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周二,STAAR Surgical(STAA.US)盘前大涨超15%,报27.15美元。消息面上,Alcon表示,已将其收购 STAAR Surgical 的报价提高到约 16 亿美元的总股权价值,高于此前的 15 亿美元。根据修订后的协议条款,Alcon 将以每股 30.75 美元的价格现金购买所有 STAAR Surgical 的流通股,高于此前每股 28 美元的报价。Alcon 表示,这笔交易现在较 STAAR 过去 90 日的成交量加权平均价格溢价 74%,较 8 月 4 日(即合并宣布前一天)STAAR 股票的收盘价溢价 66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"bb154bdedc15b71379c8c0ff5d0ebb60","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379601.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"美股异动 | STAAR Surgical(STAA.US)盘前大涨超15% Alcon将收购报价提高至16亿美元","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","STAA","BK4548","BK4198","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188320419","title":"Alcon AG - Alcon敦促STAAR股东在2025年12月19日会议之前投票支持交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1188320419","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188320419?lang=zh_cn&edition=full","pubTime":"2025-12-09 21:34","pubTimestamp":1765287248,"startTime":"0","endTime":"0","summary":"Alcon AG - Alcon敦促STAAR股东在2025年12月19日会议之前投票支持交易","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STAA","BK4198","BK4585","BK4548","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172220422","title":"Alcon AG - 新条款包括收购价格上涨及高管薪酬减少","url":"https://stock-news.laohu8.com/highlight/detail?id=1172220422","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172220422?lang=zh_cn&edition=full","pubTime":"2025-12-09 21:33","pubTimestamp":1765287232,"startTime":"0","endTime":"0","summary":"Alcon AG - 新条款包括收购价格上涨及高管薪酬减少","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4198","STAA","BK4548","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125018290","title":"Broadwood Partners 重申反对 STAAR Surgical 出售给 Alcon","url":"https://stock-news.laohu8.com/highlight/detail?id=1125018290","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125018290?lang=zh_cn&edition=full","pubTime":"2025-12-09 02:29","pubTimestamp":1765218553,"startTime":"0","endTime":"0","summary":"Broadwood Partners 重申反对 STAAR Surgical 出售给 Alcon,因其表现性征集购买过程的结束。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STAA","BK4585","BK4198","BK4548","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147895517","title":"Broadwood Partners:代理咨询公司Egan-Jones重申STAA Surgical股东投票反对出售给Alcon","url":"https://stock-news.laohu8.com/highlight/detail?id=1147895517","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147895517?lang=zh_cn&edition=full","pubTime":"2025-12-08 21:19","pubTimestamp":1765199949,"startTime":"0","endTime":"0","summary":"Broadwood Partners:代理咨询公司Egan-Jones重申其建议,STAAR Surgical的股东投票反对将公司出售给Alcon。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","STAA","BK4585","BK4588","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151506104","title":"Broadwood Partners:正努力召集STAAR Surgical股东特别会议,罢免三名董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1151506104","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151506104?lang=zh_cn&edition=full","pubTime":"2025-12-03 05:52","pubTimestamp":1764712329,"startTime":"0","endTime":"0","summary":"Broadwood Partners:正努力召集STAAR Surgical股东特别会议,罢免三名董事","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","STAA","BK4548","BK4588","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170939109","title":"异动解读 | STAAR Surgical盘中大涨5.05%,第三季度业绩强劲获投资者青睐","url":"https://stock-news.laohu8.com/highlight/detail?id=1170939109","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170939109?lang=zh_cn&edition=full","pubTime":"2025-11-07 04:12","pubTimestamp":1762459958,"startTime":"0","endTime":"0","summary":"周四盘中,STAAR Surgical Company股价大涨5.05%,引发市场关注。这波涨势主要受到该公司第三季度强劲业绩的推动,以及主要投资者的积极评价。据悉,云奇资本对STAAR Surgical的第三季度业绩表示赞赏。值得注意的是,云奇资本同时呼吁终止STAAR Surgical与Alcon的拟议销售。这一立场可能被市场解读为公司独立发展的信号,暗示STAAR Surgical有潜力通过自身实力实现更大的价值。这种战略调整的可能性也可能contributes to the positive market sentiment,进一步推动了股价的上涨。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["STAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136431818","title":"异动解读 | STAAR Surgical盘中大涨5.05%,强劲业绩及股东建议提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1136431818","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136431818?lang=zh_cn&edition=full","pubTime":"2025-11-07 04:12","pubTimestamp":1762459956,"startTime":"0","endTime":"0","summary":"STAAR Surgical Company今日盘中大涨5.05%,引发市场关注。这一显著涨幅主要源于公司发布的强劲第三季度业绩报告,以及主要股东云奇资本对公司战略的积极评价。值得注意的是,云奇资本作为STAAR Surgical的重要股东,其对公司战略的看法对投资者信心具有显著影响。该资本公司呼吁终止与Alcon的拟议销售,表明其对STAAR Surgical独立发展前景持乐观态度。投资者普遍认为,保持独立运营可能有利于STAAR Surgical充分发挥其在眼科医疗设备领域的优势,从而在长期创造更大的股东价值。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["STAA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.staar.com","stockEarnings":[{"period":"1week","weight":0.0592},{"period":"1month","weight":0.4066},{"period":"3month","weight":0.4348},{"period":"6month","weight":0.051},{"period":"1year","weight":0.4826},{"period":"ytd","weight":0.1776}],"compareEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":0.0998},{"period":"3month","weight":0.0414},{"period":"6month","weight":0.0566},{"period":"1year","weight":0.2904},{"period":"ytd","weight":0.0568}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Staar Surgical Company最初于1982年在加利福尼亚州注册成立,并于1986年在特拉华州重新注册。该公司设计、开发、制造和销售用于眼睛的植入式镜片,主要是用于矫正性屈光手术的可植入胶原镜片。公司已逐步淘汰其白内障人工晶状体产品线,以专注于其ICL产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.411765,"avgChangeRate":-0.008273},{"month":2,"riseRate":0.470588,"avgChangeRate":-0.015186},{"month":3,"riseRate":0.514286,"avgChangeRate":0.002113},{"month":4,"riseRate":0.485714,"avgChangeRate":0.044981},{"month":5,"riseRate":0.542857,"avgChangeRate":0.03919},{"month":6,"riseRate":0.617647,"avgChangeRate":0.089041},{"month":7,"riseRate":0.441176,"avgChangeRate":-0.025058},{"month":8,"riseRate":0.529412,"avgChangeRate":0.058812},{"month":9,"riseRate":0.529412,"avgChangeRate":-0.005382},{"month":10,"riseRate":0.441176,"avgChangeRate":0.030036},{"month":11,"riseRate":0.470588,"avgChangeRate":0.011395},{"month":12,"riseRate":0.352941,"avgChangeRate":0.000415}],"exchange":"NASDAQ","name":"STAAR Surgical Company","nameEN":"Staar Surgical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"STAAR Surgical Company(STAA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供STAAR Surgical Company(STAA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"STAAR Surgical Company,STAA,STAAR Surgical Company股票,STAAR Surgical Company股票老虎,STAAR Surgical Company股票老虎国际,STAAR Surgical Company行情,STAAR Surgical Company股票行情,STAAR Surgical Company股价,STAAR Surgical Company股市,STAAR Surgical Company股票价格,STAAR Surgical Company股票交易,STAAR Surgical Company股票购买,STAAR Surgical Company股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"STAAR Surgical Company(STAA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供STAAR Surgical Company(STAA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}